GLP1 Shot Tracker - Bound is a medical utility designed to help users manage GLP-1 medication regimens, including Ozempic, Wegovy, Mounjaro, and Zepbound. The app provides a centralized platform for logging injection details, tracking health metrics, and monitoring side effects to facilitate patient-provider communication.
Overview · Full Intel report in progress
The App DNA
What makes this app unique?
For Individuals currently prescribed GLP-1 medications who require a structured way to track their medication adherence and health progress.
What does it look like?
Key features
Allows users to record the date, time, dosage, and specific injection site for each weekly medication dose.
Enables users to monitor weight, calorie intake, protein consumption, and water intake to maintain a holistic view of their health journey.
Provides a dedicated space to log side effects, helping users identify patterns to discuss with their healthcare providers.
How much does it cost?
Velocity
Who built it?
Hussain Mustafa
13+ apps tracked · Medical
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for GLP1 Shot Tracker - Bound
How's the Medical market?
The rivals identified
By mySugr GmbH
Both apps serve chronic condition management through patient logging, competing for the same demographic needing clinical data for provider consultations.
- mySugr automates data entry via Accu-Chek hardware integration, whereas GLP1 Shot Tracker - Bound requires manual input.
- mySugr includes a Bolus Calculator for insulin dosing, a feature absent in GLP1 Shot Tracker - Bound.
- mySugr gates advanced reporting behind a PRO subscription, while GLP1 Shot Tracker - Bound remains fully free.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for GLP1 Shot Tracker - Bound
Where is it heading?
Bottom line
The app serves as a specialized digital logbook for GLP-1 patients, though users have noted a desire for broader ecosystem integrations like Apple Health.
Report last updated